Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Longeveron Inc
(NQ:
LGVN
)
1.870
UNCHANGED
Streaming Delayed Price
Updated: 11:52 AM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Longeveron Inc
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
Mid-Day Market Update: Crude Oil Down Over 3%; RCM Technologies Shares Jump
March 31, 2022
U.S. stocks traded lower midway through trading following the release of weekly jobless claims data.
Via
Benzinga
Analyzing Longeveron Inc. - common stock's Short Interest
March 31, 2022
Longeveron Inc. - common stock's (NASDAQ:LGVN) short percent of float has fallen 10.14% since its last report. The company recently reported that it has 412.90 thousand shares...
Via
Benzinga
Mid-Morning Market Update: US Markets Open Lower As Initial Jobless Claims Rise
March 31, 2022
U.S. stocks opened on a weak note this morning following the release of weekly jobless claims data.
Via
Benzinga
Why Longeveron Shares Are Surging Today
March 31, 2022
Longeveron Inc (NASDAQ: LGVN) shares are trading higher Thursday after the company announced the publication of results from a Phase 1 trial testing Lomecel-B on patients...
Via
Benzinga
R&D Efforts for Alzheimer’s Therapies on the Rise with over 120 Drugs in Development
March 31, 2022
Palm Beach, FL – March 31, 2022 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease (AD) is an irreversible, progressive neurodegenerative disease. It is the most common cause of dementia...
Via
FinancialNewsMedia
Why Is Longeveron (LGVN) Stock Up Today?
March 10, 2022
Longeveron is rising before the release of its Q4 2021 earnings report. Here's what investors should know about LGVN stock and why.
Via
InvestorPlace
EXCLUSIVE: Longeveron's Lomecel-B Data In Alzheimer's Disease Published In Medical Journal
March 31, 2022
Longeveron Inc (NASDAQ: LGVN) announced the publication of Phase 1 trial results of Lomecel-B on patients with mild Alzheimer's disease (AD) in the Alzheimer's & Dementia journal.
Via
Benzinga
Healthspan, Not Lifespan Should Be the Focus of Anti-Aging Research, Says Longeveron
March 30, 2022
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 24, 2022
March 24, 2022
Upgrades For iRobot Corp (NASDAQ:IRBT), Northland Capital Markets upgraded the previous rating of Market Perform to Outperform. In the fourth quarter, iRobot showed an EPS of $1....
Via
Benzinga
5 Cheap Energy Stocks Riding Oil Higher
March 23, 2022
Energy is understandably at the top of every investor's mind right now, but finding the best energy stocks requires careful consideration.
Via
InvestorPlace
My No. 2 Stock Pick For 2022 Rises 100%…
March 15, 2022
There isn't just one kind of good stock, and there isn't just one good strategy for when to sell. You need a variety of approaches.
Via
InvestorPlace
Longeveron Announces Fourth Quarter And Full Year 2021 Financial Results And Operational Progress
March 14, 2022
Currently Enrolling Clinical Trials with Lomecel-B in Three Disease Indications: Hypoplastic Left Heart Syndrome (Phase 2a), Alzheimer’s Disease (Phase 2a), and Covid-...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
March 11, 2022
Gainers CVRx (NASDAQ:CVRX) shares rose 11.6% to $7.2 during Friday's after-market session. The market value of their outstanding shares is at $156.2 million.
Via
Benzinga
Earnings Scheduled For March 11, 2022
March 11, 2022
Companies Reporting Before The Bell • The Real Good Food (NASDAQ:RGF) is estimated to report quarterly loss at $0.19 per share on revenue of $25.29 million. •...
Via
Benzinga
Amazon Stock Split 2022: Is the AMZN Split Good or Bad? 4 Analysts Weigh In.
March 10, 2022
Amazon (AMZN) stock is on the move Thursday after the e-commerce giant announced a stock split taking place later this year.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 10, 2022
Gainers Innate Pharma (NASDAQ:IPHA) stock increased by 13.7% to $3.32 during Thursday's pre-market session. The market value of their outstanding shares is at $264.6...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
March 10, 2022
Good morning, trader! We're preparing for another busy day of trading with the biggest pre-market stock movers for Thursday!
Via
InvestorPlace
23 Stocks Moving in Thursday's Pre-Market Session
March 10, 2022
Gainers Pintec Technology Holdings Limited (NASDAQ: PT) rose 55.3% to $0.7410 in pre-market trading after jumping around 14% on Wednesday. Longeveron Inc. (NASDAQ: LGVN)...
Via
Benzinga
87 Biggest Movers From Yesterday
March 10, 2022
Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares jumped 150% to close at $3.80 on Wednesday. Sunshine Biopharma, last month, priced its 1.88 million unit uplisting to...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
March 07, 2022
Gainers
Via
Benzinga
3 Moonshot Stocks For 2022
February 16, 2022
Insider trading can be highly revealing when looking for moonshot stocks to buy. Here's three with insiders buying worth looking at.
Via
InvestorPlace
Two Insider Moonshots Rising on Sudden Buying
February 10, 2022
Biotech insiders are among the most important investors to pay close attention to. Here are two that show good signs for the future.
Via
InvestorPlace
3 Stocks Insiders Are Buying on Market Turbulence
January 27, 2022
When insiders buy a stock, you should take it as a sign that they think good news is about to come out. Here are three to watch closely.
Via
InvestorPlace
41 Biggest Movers From Yesterday
January 27, 2022
Gainers Ebang International Holdings Inc. (NASDAQ: EBON) shares gained 35.4% to settle at $1.09 on Wednesday as investors weighed the Federal Reserve Reserve decision to leave...
Via
Benzinga
34 Stocks Moving In Friday's Mid-Day Session
January 21, 2022
Gainers Blue Star Foods Corp. (NASDAQ: BSFC) shares jumped 180% to $5.32 after gaining around 9% on Thursday. Bon Natural Life Limited (NASDAQ: BON) shares gained 22% to $3.91....
Via
Benzinga
53 Biggest Movers From Friday
January 24, 2022
Gainers Blue Star Foods Corp. (NASDAQ: BSFC) shares climbed 100% to close at $3.80 on Friday after gaining around 9% on Thursday. Dave Inc. (NASDAQ: DAVE) jumped 30.3% to settle...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
January 21, 2022
Good morning, investor! Let's close out the week right with a breakdown of the biggest pre-market stock movers for Friday!
Via
InvestorPlace
18 Stocks Moving in Friday's Pre-Market Session
January 21, 2022
Gainers Blue Star Foods Corp. (NASDAQ: BSFC) shares rose 422% to $9.93 in pre-market trading after gaining around 9% on Thursday. Barfresh Food Group Inc. (...
Via
Benzinga
58 Biggest Movers From Yesterday
January 07, 2022
Gainers Eargo, Inc. (NASDAQ: EAR) shares climbed 59.7% to close at $7.28 on Thurs after the company announced the Department of Justice confirmed to it that the previously-...
Via
Benzinga
33 Stocks Moving In Thursday's Mid-Day Session
January 06, 2022
Gainers Eargo, Inc. (NASDAQ: EAR) shares jumped 50.8% to $6.88 after the company announced the Department of Justice confirmed to it that the previously-announced criminal probe...
Via
Benzinga
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.